Catalyst
Slingshot members are tracking this event:
Phase 1/2 initial data of Genmab's (GMAB) Enapotamab vedotin in Solid tumors to be presented at IASLC 2019 WCLC September 8, 2019
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 08, 2019
Occurred Source:
https://s3.amazonaws.com/virtual_library_video/wclc2019/WCLC2019+Onsite+Program__vF_SEPT1.pdf
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Enapotamab Vedotin, Solid Tumors, Iaslc